These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26652960)

  • 1. [The mortality of patients with diabetes mellitus using oral antidiabetic drugs in the Czech Republic decreased over the decade of 2003-2013 and came closer to the population average].
    Brož J; Honěk P; Dušek L; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S14-20. PubMed ID: 26652960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the development of metformin and sulfonylurea prescriptions in the Czech Republic].
    Janíčková-Žďarská D; Honěk P; Dušek L; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S25-9. PubMed ID: 26652962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of diabetes compensation in patients treated with an insulin pump in the Czech Republic].
    Rušavý Z; Honěk P; Dušek L; Pavlík T; Žďarská DJ; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S39-43. PubMed ID: 26652964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of amputations among patients with diabetes mellitus in the Czech Republic from 2010 to 2014].
    Piťhová P; Honěk P; Dušek L; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S21-4. PubMed ID: 26652961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
    Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G
    Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [POET2 registry: Comparison of annual direct medical costs of treating type 2 diabetes after addition of insulin NPH or insulin glargine to oral antidiabetic therapy in the Czech Republic].
    Kvapil M; Žďarská DJ; Suchopár J; Prokeš M; Brož J
    Vnitr Lek; 2015 Jan; 61(1):24-32. PubMed ID: 25693613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data].
    Šnejdrlová M; Češka R; Janíčková-Žďárská D; Honěk P; Dušek P; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S30-7. PubMed ID: 26652963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
    Prázný M
    Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and economic benefits of the new antidiabetic drugs in the Czech Republic].
    Doležal T; Kruntorádová K
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S50-3. PubMed ID: 26652966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of maternal mortality in the Czech Republic in 2000].
    Srp B; Velebil P
    Ceska Gynekol; 2002 Sep; 67(5):268-74. PubMed ID: 12434662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Decrease in cardiovascular disease mortality in the Czech Republic from 1984 to 1993 and its possible causes].
    Skodová Z; Písa Z; Poledne R; Berka L; Cícha Z; Emrová R; Hoke M; Pikhartová J; Vojtísek P; Grafnetter D; Wiesner E; Hrdlicková K; Havlíková A; Bobák M; Vorlícek J; Paclt M; Lánská V
    Cas Lek Cesk; 1997 Jun; 136(12):373-9. PubMed ID: 9333509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The SPACE project (Stav Pacientů Akceptovaných diabetologem Cestou Exportu/The Health Records of Patients Accepted by a Diabetologist by way of Export)].
    Kvapil M
    Vnitr Lek; 2016; 62(9 Suppl 3):22-27. PubMed ID: 27734687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment strategy of type 2 diabetes used in Czech Republic after metformin therapy failure].
    Svačina Š; Ovesná P; Kuhn M; Nováčková M
    Vnitr Lek; 2017; 63(10):647-657. PubMed ID: 29127747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant tumors of the esophagus in the Czech Republic].
    Duda M; Adamcík L; Dusek L; Skrovina M; Jínek T
    Rozhl Chir; 2012 Mar; 91(3):132-40. PubMed ID: 22881077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
    Clin Ther; 2007; 29 Spec No():1306-15. PubMed ID: 18046930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
    Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
    Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities of Potential Gains in Life Expectancy Development between the Slovak Republic and the Czech Republic.
    Vagašová T; Gavurová B
    Cent Eur J Public Health; 2017 Dec; 25 Suppl 2():S10-S15. PubMed ID: 29524364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.